Why Asuragen Chooses Seraseq® ctDNA V2

Asuragen relies on SeraCare’s liquid biopsy products to help streamline sensitive assays and workflows in order to produce high-quality results. Associate Director of Bioinformatics at Asuragen, Brian Haynes, PhD, talks about the importance of high-quality, patient-like reference materials and LOD experiments.

We’re basically getting more bang for our buck from those reference materials because they have more mutations representing within them. – Brian Haynes, PhD

Watch this video to hear about his experience working with Seraseq ctDNA V2 in the lab. 

 

See what others are saying about SeraCare by visiting our Customer Stories.

Related Content

Sandi Deans, UK NEQAS, Discusses the Need for Patient-like Materials

UK NEQAS

Sandi Deans, UK NEQAS, Discusses the Need for Patient-like Materials

With medical laboratory standards being more closely scrutinized, UK NEQAS turns to SeraCare to aide in their awareness of sensitivity, specificity, and accuracy in limit of detection.

iQ NGS QC Management Transforms Genomic Medicine Lab at the University of Illinois

University of Illinois

iQ NGS QC Management Transforms Genomic Medicine Lab at the University of Illinois

Working in a lab with major focuses of clinical diagnostics and translational research, Gayatry Mohapatra, PhD, understands the needs for high-quality software to help with data management.

Reference Materials Prove Instrumental for MD Anderson Cancer Center Lab

MD Anderson Cancer Center

Reference Materials Prove Instrumental for MD Anderson Cancer Center Lab

SeraCare’s reference materials give Jawad Manekia, PhD, supervisor of a molecular diagnostics laboratory at MD Anderson Cancer Center, the confidence he needs to be able to report that an assay passes quality control.